Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Sweden Flisning & Krossning Av Trä 2026-02-14
Norway 77491 Ra Klm Department Of Medical Biochemistry Analysis Instrument 2026-02-14
Germany Completion Of Non -existing Discount Agreements According To § 130 A Para. 8 Sgb V To Biosimilar Active Ingredients From 01.10.2025 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Fluorouracil (efudix) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Olanzapine (trs) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Ciclosporin (ikervis) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Finished Medicinal Product Acarizax-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Dexamethasone (ozurdex) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Apixaban Vv 86 2026-02-15
Germany Completion Not Excl.according To Section 130a (8) Sgb V By Means Of An Open House Model To The Active Ingredient Rivaroxaban (atc Code According To Who: B01af01), Embedded.on The Power Strengths 10mg/15mg/20mg 2026-02-15
Whats app